EXACT Sciences Corp. (DELISTED) (EXAS:DL)
104.91
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
EXACT Sciences EPS Diluted (Quarterly) : -0.453 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.453 |
| September 30, 2025 | -0.1035 |
| June 30, 2025 | -0.0063 |
| March 31, 2025 | -0.5418 |
| December 31, 2024 | -4.666 |
| September 30, 2024 | -0.2069 |
| June 30, 2024 | -0.0858 |
| March 31, 2024 | -0.6045 |
| December 31, 2023 | -0.2748 |
| September 30, 2023 | 0.0043 |
| June 30, 2023 | -0.4496 |
| March 31, 2023 | -0.4152 |
| December 31, 2022 | -0.7194 |
| September 30, 2022 | -0.8405 |
| June 30, 2022 | -0.9416 |
| March 31, 2022 | -1.037 |
| December 31, 2021 | -1.279 |
| September 30, 2021 | -0.9707 |
| June 30, 2021 | -1.032 |
| March 31, 2021 | -0.1839 |
| December 31, 2020 | -2.674 |
| September 30, 2020 | -1.349 |
| June 30, 2020 | -0.4548 |
| March 31, 2020 | -0.9088 |
| December 31, 2019 | 0.5443 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.3128 |
| June 30, 2019 | -0.298 |
| March 31, 2019 | -0.657 |
| December 31, 2018 | -0.4389 |
| September 30, 2018 | -0.3698 |
| June 30, 2018 | -0.2979 |
| March 31, 2018 | -0.3258 |
| December 31, 2017 | -0.18 |
| September 30, 2017 | -0.23 |
| June 30, 2017 | -0.27 |
| March 31, 2017 | -0.32 |
| December 31, 2016 | -0.34 |
| September 30, 2016 | -0.36 |
| June 30, 2016 | -0.46 |
| March 31, 2016 | -0.49 |
| December 31, 2015 | -0.41 |
| September 30, 2015 | -0.45 |
| June 30, 2015 | -0.44 |
| March 31, 2015 | -0.40 |
| December 31, 2014 | -0.38 |
| September 30, 2014 | -0.39 |
| June 30, 2014 | -0.24 |
| March 31, 2014 | -0.23 |
| December 31, 2013 | -0.17 |
| September 30, 2013 | -0.16 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.241 |
| Illumina, Inc. | 0.8701 |
| Mettler-Toledo International, Inc. | 8.332 |
| Natera, Inc. | -0.6013 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -85.96M |
| Revenue (Quarterly) | 878.38M |
| Total Expenses (Quarterly) | 964.34M |
| Enterprise Value | 21.60B |
| Gross Profit Margin (Quarterly) | 70.11% |
| Profit Margin (Quarterly) | -9.79% |
| Earnings Yield | -1.05% |
| Normalized Earnings Yield | -0.874 |